University of Texas MD Anderson Cancer Center, Houston, USA
Dr. Charles M. Balch is the founding Editor-in-Chief of Annals of Surgical Oncology,. He is the editor of Cutaneous Melanoma, regarded as the authoritative textbook on melanoma, now in its 5th edition; is founding Editor-in-Chief of Patient Resource Cancer Guides, and was the founding Editor-in-Chief of the journal Breast Diseases. He is Research Professor of Surgery, Department of Surgical Oncology at the University of Texas MD Anderson Cancer Center. His areas of clinical expertise include breast cancer, dermatopathology, melanoma, skin cancer and surgical oncology.
Dr. Balch leads a distinguished career as a surgical oncologist and authority in melanoma and breast cancer. He has authored over 630 publications on topics such as clinical investigations involving the natural history of melanoma, prognostic factors predicting clinical outcomes, standards of surgical treatment, and the conduct and methodology of clinical research and immunology. Dr. Balch is considered one of the leading melanoma experts in the world.
Dr. Balch is the editor of Cutaneous Melanoma, regarded as the authoritative textbook on melanoma, now in its fifth edition. He is the founding editor-in-chief of the Annals of Surgical Oncology and is chair of the Melanoma Staging Committee of the American Joint Committee on Cancer, which determines the staging criteria for melanomas worldwide. He has held major leadership roles in clinical research in three comprehensive cancer centers (UAB, MD Anderson and City of Hope).
He has been a principal investigator or co-PI of numerous clinical trials, including 10 phase III trials, most of which were NCI-funded National Phase III trials. He has organized or participated in randomized surgical trials that have defined the current standards of melanoma surgery. Dr. Balch’s research interests include melanoma and breast cancer clinical trials, prognostic and predictive factors of cancer outcomes, biological therapy for cancer, sentinel lymph nodes and cancer biomarkers.
Dr. Balch earned his M.D from Columbia University College of Physicians and Surgeons. He completed his residencies at the University of Alabama at Birmingham and performed a fellowship in immunology at Scripps Clinic and Research Foundation. He previously served as the director of the Johns Hopkins Clinical Research Network (JHCRN).